Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cigarette Smoke Extract Exposure Affects Innate Immune Response, Metabolic Rate, and Locomotor Activity of Drosophila melanogaster.

Lung·2026
Same author

The effect of asymmetrical vs. symmetrical high flow nasal cannula on inspiratory effort.

Critical care (London, England)·2026
Same author

Sputum Exosomal microRNAs as Non-Invasive Biomarkers in COPD: A Cross-Sectional Study.

Biomedicines·2025
Same author

Two autochthonous cases of Crimean-Congo haemorrhagic fever and the One Health response, Thessaly, Greece, 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2025
Same author

Immune Dysregulation in Sepsis. A Narrative Review for the Clinicians.

Biomedicines·2025
Same author

Comparison of maximal inspiratory pressure to resistive breathing for weaning prediction.

Respiratory physiology & neurobiology·2025

Related Experiment Video

Updated: May 29, 2026

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Serum amyloid alpha in parapneumonic effusions.

Vagelis Boultadakis1, Vasilis Skouras, Demosthenes Makris

  • 1Respiratory Department, University Hospital of Larissa, Biopolis, Larissa, Greece.

Mediators of Inflammation
|August 31, 2011
PubMed
Summary

Serum amyloid alpha (SAA) is elevated in complicated parapneumonic effusion (PPE), aiding diagnosis. However, SAA did not predict long-term pleural complications in this study.

More Related Videos

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
07:03

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

Related Experiment Videos

Last Updated: May 29, 2026

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa
07:27

Methods for Detecting Cytotoxic Amyloids Following Infection of Pulmonary Endothelial Cells by Pseudomonas aeruginosa

Published on: July 12, 2018

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration
07:03

Bronchoalveolar Lavage of Murine Lungs to Analyze Inflammatory Cell Infiltration

Published on: May 4, 2017

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
12:01

Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein

Published on: May 30, 2015

Area of Science:

  • Pulmonology
  • Biomarker Research
  • Infectious Diseases

Background:

  • Parapneumonic effusion (PPE) diagnosis and management remain challenging.
  • Identifying reliable biomarkers for PPE severity and outcomes is crucial.

Purpose of the Study:

  • To evaluate serum amyloid alpha (SAA) levels in pleural fluid for diagnosing parapneumonic effusion (PPE).
  • To assess the diagnostic performance of SAA in differentiating PPE subtypes (uncomplicated, complicated, empyema).
  • To investigate the association between SAA levels and 6-month outcomes, including pleural thickening or loculations.

Main Methods:

  • Prospective study of 57 patients with PPE.
  • Measurement of SAA, CRP, TNF-α, IL-1β, and IL-6 in serum and pleural fluid.
  • 6-month follow-up to assess pleural complications.

Main Results:

  • Pleural SAA levels were significantly higher in complicated PPE (CPE) versus uncomplicated PPE (UPE).
  • CRP levels were elevated in empyema (EMP) and CPE compared to UPE.
  • No significant association was found between SAA levels and 6-month outcomes or development of pleural thickening/loculations.

Conclusions:

  • SAA may serve as a useful biomarker for diagnosing complicated PPE.
  • SAA demonstrated potential in differentiating uncomplicated from complicated PPE.
  • SAA levels were not predictive of long-term pleural complications like thickening or loculations.